Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Study Identifier
M03-651
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Rheumatoid Arthritis
  • Study Drug
  • adalimumab
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    20+ years

    Protocol Summary

    The purpose of the study is to assess the long-term safety and tolerability of repeated

    administration of adalimumab in Japanese subjects with rheumatoid arthritis.

    Study Locations

    Location
    Status
    Location
    Tokyo, Metropolis, Japan
    Status
    Not applicable
    Location
    Aichi, Prefecture, Japan
    Status
    Not applicable
    Location
    Chiba, Prefecture, Japan
    Status
    Not applicable
    Location
    Ehime, Prefecture, Japan
    Status
    Not applicable
    Location
    Fukui, Prefecture, Japan
    Status
    Not applicable
    Location
    Fukuoka, Prefecture, Japan
    Status
    Not applicable
    Showing {first} - {last} of {total} Results